By: Emily Jones – CBN News;

JERUSALEM, Israel – An Israeli pharmaceutical company is donating to US hospitals more than 6 million doses of hydroxychloroquine, a malaria drug touted by President Donald Trump and others as a potential new treatment for COVID-19 patients.

Teva, a pharmaceutical giant in Israel, has announced it will begin donating millions of hydroxychloroquine sulfate tablets to hospitals across the US starting March 31.

“Immediately upon learning of the potential benefit of hydroxychloroquine, Teva began to assess supply and to urgently acquire additional ingredients to make more product while arranging for all of what we had to be distributed immediately,” said Brendan O’Grady, Teva Executive Vice President North America Commercial, in a statement.

Leave a Reply